3-D Matrix (7777) AI Stock Analysis

• Market Cap: ¥34.85B
• Dividend Yield: N/A
• Average Volume (3M): 3.91M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.73
• Revenue Growth: 45.67%
• EPS Growth: 29.44%
• Country: JP
• Employees: 106
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 6.89
• Shares Outstanding: 114,261,150
• 10 Day Avg. Volume: 6,263,830
• 30 Day Avg. Volume: 3,912,223
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥286.72
• Price Target Upside: -5.99% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 52 Neutral
• Price Target: ¥289.00 ▼(-5.25% Downside)

The overall stock score is primarily impacted by the company's weak financial performance, characterized by high leverage and consistent losses. While technical analysis shows positive momentum, the valuation remains unattractive due to negative earnings. The absence of earnings call data and corporate events means these factors do not influence the score.

3-D Matrix Business Overview & Revenue Model

Company Description

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.

How the Company Makes Money

3-D Matrix generates revenue primarily through the sale of its biomaterials and hydrogel products to hospitals, research institutions, and pharmaceutical companies. The company has established key partnerships with medical device manufacturers and research organizations, allowing it to leverage collaborative projects and co-development agreements. Additionally, revenue is supplemented by licensing agreements for its proprietary technologies, which provide a continuous stream of income as well as potential royalties from future product developments. The company may also engage in government and private grants for research and development, further contributing to its earnings.

3-D Matrix Financial Statement Overview

Summary

3-D Matrix faces significant financial challenges, with consistent losses and high leverage. While there is some revenue growth, profitability and cash flow remain areas of concern. The company needs to focus on reducing costs, improving operational efficiency, and managing debt to enhance financial stability and performance.

Income Statement

The company has shown some revenue growth over the years, with a 4.05% increase in the latest period. However, profitability remains a significant concern, with negative net profit margins and EBIT margins indicating ongoing operational challenges. The gross profit margin is relatively healthy at 63.81%, but the consistent net losses highlight the need for improved cost management and revenue generation.

Balance Sheet

The balance sheet reveals high leverage, with a debt-to-equity ratio of 1.33, indicating significant reliance on debt financing. The return on equity is negative, reflecting the company's inability to generate profits from shareholders' equity. The equity ratio is low, suggesting potential financial instability and risk in meeting long-term obligations.

Cash Flow

Cash flow analysis shows negative operating cash flow, which is a concern for sustainability. The free cash flow to net income ratio is slightly above 1, indicating that free cash flow is covering net losses. However, the negative free cash flow growth rate and operating cash flow coverage ratio highlight liquidity challenges and the need for improved cash management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.66B	6.93B	4.59B	2.31B	1.51B	1.02B
Gross Profit	4.76B	4.42B	3.09B	1.29B	661.01M	304.91M
EBITDA	-317.43M	-2.40B	59.13M	715.00M	843.00M	638.00M
Net Income	-949.00M	-2.50B	-255.50M	-2.45B	-1.89B	-2.01B
Balance Sheet
Total Assets	7.04B	6.51B	5.89B	5.83B	5.61B	3.51B
Cash, Cash Equivalents and Short-Term Investments	1.98B	1.58B	1.36B	1.17B	2.85B	1.14B
Total Debt	3.20B	2.94B	4.17B	4.37B	3.67B	1.46B
Total Liabilities	4.40B	4.30B	5.53B	5.30B	4.15B	1.85B
Stockholders Equity	2.64B	2.22B	353.31M	524.77M	1.46B	1.66B
Cash Flow
Free Cash Flow	0.00	-1.73B	-1.90B	-4.60B	-2.92B	-3.28B
Operating Cash Flow	0.00	-1.71B	-1.90B	-4.59B	-2.90B	-3.25B
Investing Cash Flow	0.00	-33.30M	-29.76M	-81.50M	-79.86M	-160.32M
Financing Cash Flow	0.00	2.01B	2.06B	2.96B	4.66B	3.46B

3-D Matrix Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 305.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7777, the sentiment is Positive. The current price of 305 is above the 20-day moving average (MA) of 232.65, above the 50-day MA of 223.60, and above the 200-day MA of 166.34, indicating a bullish trend. The MACD of 12.56 indicates Negative momentum. The RSI at 64.40 is Neutral, neither overbought nor oversold. The STOCH value of 79.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7777.

3-D Matrix Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5187	78 Outperform	9.12B	12.32	5.34%	3.69%	3.38%	88.65%
7792	77 Outperform	13.98B	11.05	24.92%	1.95%	12.36%	38.55%
7963	75 Outperform	8.95B	11.47	5.54%	1.92%	9.07%	43.42%
6678	74 Outperform	17.43B	16.88	0.00%	3.33%	-8.07%	-38.21%
7600	56 Neutral	13.25B	-19.79	-1.87%	2.98%	4.84%	-148.94%
7777	52 Neutral	¥34.85B	―	-49.32%	―	45.67%	29.44%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%